US Capitol Capsule: Without transparency, battle for public support a losing game
This article was originally published in Scrip
Whether it was the debate over US presidential candidate Mitt Romney's unwillingness to disclose more than two years of his income tax filings or the White House's vagueness on the specifics of how the across-the-board spending cuts would affect federal agencies and programs under sequestration come January if no deficit agreement is reached, one overarching theme reverberated in Washington last week: The need for more transparency.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.